Barclays’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-70,000
Closed -$3.07M 5299
2023
Q4
$3.07M Buy
+70,000
New +$3.19M ﹤0.01% 2541
2023
Q1
Sell
-202,700
Closed -$10.3M 5282
2022
Q4
$10.3M Buy
+202,700
New +$10.6M ﹤0.01% 1193
2020
Q1
Sell
-12,640
Closed -$296K 6377
2019
Q4
$296K Sell
12,640
-138,000
-92% -$2.96M ﹤0.01% 4740
2019
Q3
$3.46M Buy
150,640
+130,360
+643% +$2.98M ﹤0.01% 2225
2019
Q2
$521K Sell
20,280
-3,829
-16% -$119K ﹤0.01% 4281
2019
Q1
$873K Sell
24,109
-20,911
-46% -$717K ﹤0.01% 3550
2018
Q4
$1.3M Buy
45,020
+25,200
+127% +$1.09M ﹤0.01% 2848
2018
Q3
$1.3M Buy
19,820
+5,300
+37% +$344K ﹤0.01% 3371
2018
Q2
$947K Sell
14,520
-7,580
-34% -$475K ﹤0.01% 3349
2018
Q1
$1.22M Sell
22,100
-9,540
-30% -$566K ﹤0.01% 2986
2017
Q4
$2.11M Buy
31,640
+15,180
+92% +$896K ﹤0.01% 2378
2017
Q3
$969K Buy
16,460
+5,280
+47% +$258K ﹤0.01% 3030
2017
Q2
$492K Sell
11,180
-8,420
-43% -$436K ﹤0.01% 3545
2017
Q1
$1.15M Sell
19,600
-1,360
-6% -$81.5K ﹤0.01% 2618
2016
Q4
$1.23M Buy
20,960
+17,600
+524% +$1M ﹤0.01% 2554
2016
Q3
$176K Buy
3,360
+760
+29% +$34.1K ﹤0.01% 4064
2016
Q2
$101K Buy
2,600
+1,240
+91% +$45.4K ﹤0.01% 4398
2016
Q1
$41K Sell
1,360
-55,260
-98% -$1.27M ﹤0.01% 4889
2015
Q4
$1.42M Buy
56,620
+46,720
+472% +$1.71M ﹤0.01% 2301
2015
Q3
$297K Buy
9,900
+4,200
+74% +$161K ﹤0.01% 3811
2015
Q2
$314K Sell
5,700
-5,640
-50% -$359K ﹤0.01% 3837
2015
Q1
$624K Sell
11,340
-7,880
-41% -$496K ﹤0.01% 3385
2014
Q4
$1.25M Sell
19,220
-7,160
-27% -$609K ﹤0.01% 2988
2014
Q3
$2.77M Buy
26,380
+2,520
+11% +$278K ﹤0.01% 2357
2014
Q2
$2.74M Buy
23,860
+1,720
+8% +$199K ﹤0.01% 2302
2014
Q1
$2.32M Sell
22,140
-10,500
-32% -$994K ﹤0.01% 2403
2013
Q4
$2.94M Sell
32,640
-400
-1% -$36.4K ﹤0.01% 2294
2013
Q3
$2.81M Buy
33,040
+1,040
+3% +$90.5K ﹤0.01% 2216
2013
Q2
$2.71M Buy
+32,000
New +$2.96M ﹤0.01% 2213

Other funds holding OVV

Barclays's OVV Position: Q1 2026 in Review

Barclays reduced its Ovintiv (OVV) stake by 31% in Q1 2026, selling an estimated $11.1M and leaving 521,764 shares worth $31M. The position accounts for 0.01% of the portfolio, ranked #922.

Barclays first reported a position in OVV in Q2 2013 and has held it in 44 quarters since. The position peaked at $60.3M in Q3 2023. 609 funds tracked by Wall St. Rank hold OVV as of Q1 2026.

  • Barclays held 521,764 shares of Ovintiv worth $31M as of Q1 2026.
  • Barclays sold 230,089 Ovintiv shares in Q1 2026, an estimated $11.1M.
  • Ovintiv made up 0.01% of Barclays's portfolio in Q1 2026, its #922 holding.
  • Barclays first reported a position in Ovintiv in Q2 2013 and has held it in 44 quarters since.
  • Barclays's Ovintiv position peaked at $60.3M in Q3 2023.
  • 609 funds tracked by Wall St. Rank held Ovintiv as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.